CapsoVision, Inc. (CV)

Market Cap	338.75M
Revenue (ttm)	13.56M +12.6%
Net Income	-26.97M
EPS	-0.75
Shares Out	49.96M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	74,408
Open	6.61
Previous Close	6.65
Day's Range	6.50 - 6.84
52-Week Range	3.43 - 15.37
Beta	n/a
Analysts	Strong Buy
Price Target	10.00 (+47.49%)
Earnings Date	May 14, 2026

About CV

CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps, as well as develops CapsoColon 3D for large intestines (colon). It also provides CapsoCloud cloud-based software-as-a-service ecosystem as a...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Jul 2, 2025
• Employees: 99
• Stock Exchange: NASDAQ
• Ticker Symbol: CV
• Website: https://capsovision.com

Financial Performance

In 2025, CapsoVision's revenue was $13.55 million, an increase of 15.29% compared to the previous year's $11.76 million. Losses were -$25.32 million, 27.2% more than in 2024.

Analyst Summary

According to one analyst, the rating for CV stock is "Strong Buy" and the 12-month stock price target is $10.0.

Price Target

$10.0

(47.49% upside)

Analyst Consensus: Strong Buy